Advanced Search:
Equity Index Forex Crypto Commodity

AMPH - Amphastar Pharmaceuticals

$41.22  0.38 (0.94%)

Updated: 11:10 Apr 26, 2024 EST

Next Hour's AI Forecast

N/A

Avg. Accuracy (AI)

N/A

Next Session's AI Forecast

N/A

Avg. Accuracy (AI)

N/A

Next Week's AI Forecast

N/A

Trend's Accuracy (AI)

N/A

Amphastar Pharmaceuticals's Position Within the Industry
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)

AMPHASTAR PHARMACEUTICALS - HISTORICAL DATA 6M

  • Last price

    $ 41.22

  • Daily change

    $ 0.38

  • Previous Close

    $ 40.83

  • Last Updated

    11:10 Apr 26, 2024 EST

CURRENT VOLATILITY

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
0 0.18 -0.62 -0.24 -0.01

CURRENT VOLATILITY RANK

Variation from the lowest to the highest value in a period.

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
0 1.54 1.82 1.95 1.92

STOCHASTIC METRIC

The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.

OVERSOLD
OVERBOUGHT
Curr. Week Next Week Curr. Month Curr. Quarter
N/A N/A 92.77% 12.55%

MOVING AVERAGE METRIC

5 Sessions Change 5 Sessions 20 Sessions Change 20 Sessions 50 Sessions Change 50 Sessions 200 Sessions
0 -100% 40.73 -1.67% 41.42 -18.99% 51.13

RSI METRIC

RS Hour RSI Hour RS Day RSI Day
0.57 43.18 0.79 36.31

Amphastar Pharmaceuticals Technical Analysis News

Amphastar Pharmaceuticals

11570 6th Street
Rancho Cucamonga, CA 91730
United States
909 980 9484
https://www.amphastar.com

Description

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

Corporate Governance

Amphastar Pharmaceuticals, Inc.’s ISS Governance QualityScore as of December 28, 2022 is 6. The pillar scores are Audit: 2; Board: 9; Shareholder Rights: 5; Compensation: 5.

AMPHASTAR PHARMACEUTICALS'S HOLDERS RANK

List of holders with stock participation in Amphastar Pharmaceuticals.

Holder Rank Holder Shares Date Reported % Out Value